| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
|
Khaki, Ali Raza
|
|
|
4 |
3 |
p. 464-472
|
artikel
|
| 2 |
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
|
Bates, Anthony S.
|
|
|
4 |
3 |
p. 405-423
|
artikel
|
| 3 |
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease
|
Erickson, Andrew
|
|
|
4 |
3 |
p. 358-369
|
artikel
|
| 4 |
Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?—A Systematic Diagnostic Test Accuracy Review
|
Hettiarachchi, Dinul
|
|
|
4 |
3 |
p. 426-436
|
artikel
|
| 5 |
Contemporary Imaging Technologies for Men with Rising Prostate-specific Antigen After Radical Prostatectomy and Before Early Salvage Irradiation: Where Do We Stand?
|
Bossi, Alberto
|
|
|
4 |
3 |
p. 356-357
|
artikel
|
| 6 |
Corrigendum to ‘Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)’ [European Urology Oncology 3 (2021) 256–263]
|
Marchioni, Michele
|
|
|
4 |
3 |
p. 517
|
artikel
|
| 7 |
Data-driven Focal Therapy for Localized Prostate Cancer: A Wake-up Call
|
Shah, Ankeet
|
|
|
4 |
3 |
p. 424-425
|
artikel
|
| 8 |
Defining Risk Categories for a Significant Decline in Estimated Glomerular Filtration Rate After Robotic Partial Nephrectomy: Implications for Patient Follow-up
|
Martini, Alberto
|
|
|
4 |
3 |
p. 498-501
|
artikel
|
| 9 |
Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?
|
Burger, Maximilian
|
|
|
4 |
3 |
p. 510-514
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
4 |
3 |
p. i-ii
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
4 |
3 |
p. iii-vi
|
artikel
|
| 12 |
Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate Cancer
|
Vázquez, Ramiro
|
|
|
4 |
3 |
p. 437-446
|
artikel
|
| 13 |
Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action
|
Bhanvadia, Sumeet K.
|
|
|
4 |
3 |
p. 396-404
|
artikel
|
| 14 |
Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care
|
Lawson, Keith A.
|
|
|
4 |
3 |
p. 494-497
|
artikel
|
| 15 |
How to Select the Optimal Candidates for Renal Mass Biopsy
|
Martini, Alberto
|
|
|
4 |
3 |
p. 506-509
|
artikel
|
| 16 |
In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice?
|
Yekedüz, Emre
|
|
|
4 |
3 |
p. 515-516
|
artikel
|
| 17 |
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer
|
Deek, Matthew P.
|
|
|
4 |
3 |
p. 447-455
|
artikel
|
| 18 |
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era
|
Bellmunt, Joaquim
|
|
|
4 |
3 |
p. 502-505
|
artikel
|
| 19 |
Personalized Follow-up in Clinical Stage I Testicular Germ Cell Tumors: The Future is Beginning
|
Heidenreich, Axel
|
|
|
4 |
3 |
p. 492-493
|
artikel
|
| 20 |
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery—Results from RECUR Consortium
|
Abu-Ghanem, Yasmin
|
|
|
4 |
3 |
p. 473-482
|
artikel
|
| 21 |
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature
|
Abrams-Pompe, Raisa S.
|
|
|
4 |
3 |
p. 370-395
|
artikel
|
| 22 |
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
|
Szabados, Bernadett
|
|
|
4 |
3 |
p. 456-463
|
artikel
|
| 23 |
Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review
|
Valle, Luca
|
|
|
4 |
3 |
p. 339-355
|
artikel
|
| 24 |
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
|
Lobo, João
|
|
|
4 |
3 |
p. 483-491
|
artikel
|
Tijdschrift beschrijving